Cite Filings / NAMS / 0001193125-24-280472
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13D/A

Beneficial Ownership Report

NewAmsterdam Pharma Co N.V. · Filed 2024-12-17 · Acc 0001193125-24-280472

Documents 1

  • SC 13D/A Beneficial Ownership Report , d913199dsc13da.htm

Around this filing

  • 2024-12-20 4 10% owner sold 157,234 shares at an average $25.86 ($4,066,714)
  • 2024-12-18 4 10% owner sold 115,480 shares at an average $25.95 ($2,996,156)
  • 2024-12-17 SC 13D/A Beneficial Ownership Report
  • 2024-12-17 SC 13D/A Beneficial Ownership Report
  • 2024-12-17 SC 13D/A Beneficial Ownership Report
  • 2024-12-17 4 Options or other derivatives
  • 2024-12-16 4 10% owner sold 191,762 shares at an average $25.34 ($4,859,875)

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · RA Capital Management, L.P. 9.9%
  2. 2026-11-16 SCHEDULE 13G · JANUS HENDERSON GROUP Ltd. 7.5%
Loading d913199dsc13da.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…